Italia markets closed

BMY Sep 2024 50.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,9400+0,0800 (+9,30%)
Alla chiusura: 01:36PM EDT
Schermo intero
Chiusura precedente0,8600
Aperto0,8800
Denaro0,9100
Lettera0,9500
Prezzo d'esercizio50,00
Scadenza2024-09-20
Min-Max giorno0,8800 - 0,9400
Contratto - Min-MaxN/D
Volume69
Open Interest1,82k
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri